114 related articles for article (PubMed ID: 15364743)
1. Prothrombotic activity is increased in patients with nonvalvular atrial fibrillation and risk factors for embolism.
Inoue H; Nozawa T; Okumura K; Jong-Dae L; Shimizu A; Yano K
Chest; 2004 Sep; 126(3):687-92. PubMed ID: 15364743
[TBL] [Abstract][Full Text] [Related]
2. Nonvalvular atrial fibrillation: evidence for a prothrombotic state.
Kahn SR; Solymoss S; Flegel KM
CMAJ; 1997 Sep; 157(6):673-81. PubMed ID: 9307553
[TBL] [Abstract][Full Text] [Related]
3. Accumulation of risk factors enhances the prothrombotic state in atrial fibrillation.
Ohara K; Inoue H; Nozawa T; Hirai T; Iwasa A; Okumura K; Lee JD; Shimizu A; Hayano M; Yano K
Int J Cardiol; 2008 Jun; 126(3):316-21. PubMed ID: 17689760
[TBL] [Abstract][Full Text] [Related]
4. D-dimer level influences thromboembolic events in patients with atrial fibrillation.
Nozawa T; Inoue H; Hirai T; Iwasa A; Okumura K; Lee JD; Shimizu A; Hayano M; Yano K
Int J Cardiol; 2006 Apr; 109(1):59-65. PubMed ID: 15992948
[TBL] [Abstract][Full Text] [Related]
5. Left atrial appendage function and abnormal hypercoagulability in patients with atrial flutter.
Sakurai K; Hirai T; Nakagawa K; Kameyama T; Nozawa T; Asanoi H; Inoue H
Chest; 2003 Nov; 124(5):1670-4. PubMed ID: 14605033
[TBL] [Abstract][Full Text] [Related]
6. Relationship between plasma (D)-dimer level and cerebral infarction volume in patients with nonvalvular atrial fibrillation.
Matsumoto M; Sakaguchi M; Okazaki S; Furukado S; Tagaya M; Etani H; Shimazu T; Yoshimine T; Mochizuki H; Kitagawa K
Cerebrovasc Dis; 2013; 35(1):64-72. PubMed ID: 23428999
[TBL] [Abstract][Full Text] [Related]
7. Effects of anticoagulation intensity on hemostatic markers in patients with non-valvular atrial fibrillation.
Nozawa T; Inoue H; Iwasa A; Okumura K; Jong-dae L; Shimizu A; Hayano M; Yano K
Circ J; 2004 Jan; 68(1):29-34. PubMed ID: 14695462
[TBL] [Abstract][Full Text] [Related]
8. Atrial fibrillation and hypercoagulability: dependent on clinical factors or/and on genetic alterations?
Hatzinikolaou-Kotsakou E; Kartasis Z; Tziakas D; Hotidis A; Stakos D; Tsatalas K; Bourikas G; Kotsakou ME; Hatseras DI
J Thromb Thrombolysis; 2003 Dec; 16(3):155-61. PubMed ID: 15087601
[TBL] [Abstract][Full Text] [Related]
9. Thoracic aortic plaque enhances hypercoagulability in patients with nonrheumatic atrial fibrillation.
Nakagawa K; Hirai T; Sakurai K; Ohara K; Nozawa T; Inoue H
Circ J; 2007 Jan; 71(1):52-6. PubMed ID: 17186978
[TBL] [Abstract][Full Text] [Related]
10. Aortic spontaneous echocardiographic contrast and hemostatic markers in patients with nonrheumatic atrial fibrillation.
Nakagawa K; Hirai T; Shinokawa N; Takashima S; Nozawa T; Asanoi H; Inoue H
Chest; 2002 Feb; 121(2):500-5. PubMed ID: 11834664
[TBL] [Abstract][Full Text] [Related]
11. Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation.
Habara S; Dote K; Kato M; Sasaki S; Goto K; Takemoto H; Hasegawa D; Matsuda O
Eur Heart J; 2007 Sep; 28(18):2217-22. PubMed ID: 17716991
[TBL] [Abstract][Full Text] [Related]
12. High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy.
Vene N; Mavri A; Kosmelj K; Stegnar M
Thromb Haemost; 2003 Dec; 90(6):1163-72. PubMed ID: 14652652
[TBL] [Abstract][Full Text] [Related]
13. Markers of thrombin and platelet activity in patients with atrial fibrillation: correlation with stroke among 1531 participants in the stroke prevention in atrial fibrillation III study.
Feinberg WM; Pearce LA; Hart RG; Cushman M; Cornell ES; Lip GY; Bovill EG
Stroke; 1999 Dec; 30(12):2547-53. PubMed ID: 10582976
[TBL] [Abstract][Full Text] [Related]
14. Impact of decreased renal function on coagulation and fibrinolysis in patients with non-valvular atrial fibrillation.
Tanaka H; Sonoda M; Kashima K; Tanaka Y; Nakamura K; Nuruki N; Tsubouchi H
Circ J; 2009 May; 73(5):846-50. PubMed ID: 19346661
[TBL] [Abstract][Full Text] [Related]
15. Increased tissue plasminogen activator levels in patients with nonvalvular atrial fibrillation.
Kahn SR; Solymoss S; Flegel KM
CMAJ; 1997 Sep; 157(6):685-9. PubMed ID: 9307554
[TBL] [Abstract][Full Text] [Related]
16. Association of hemostatic markers with atrial fibrillation: a meta-analysis and meta-regression.
Wu N; Tong S; Xiang Y; Wu L; Xu B; Zhang Y; Ma X; Li Y; Song Z; Zhong L
PLoS One; 2015; 10(4):e0124716. PubMed ID: 25884835
[TBL] [Abstract][Full Text] [Related]
17. Hypercoagulopathy in stroke patients with nonvalvular atrial fibrillation: hematologic and cardiologic investigations.
Turgut N; Akdemir O; Turgut B; Demir M; Ekuklu G; Vural O; Ozbay G; Utku U
Clin Appl Thromb Hemost; 2006 Jan; 12(1):15-20. PubMed ID: 16444430
[TBL] [Abstract][Full Text] [Related]
18. Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin.
Lip GY; Lip PL; Zarifis J; Watson RD; Bareford D; Lowe GD; Beevers DG
Circulation; 1996 Aug; 94(3):425-31. PubMed ID: 8759084
[TBL] [Abstract][Full Text] [Related]
19. [Predictive value of coagulative molecular markers for thromboembolism in patients with nonvalvular atrial fibrillation: prospective five-year follow-up study].
Enta K; Iwade K; Aosaki M; Uchida T; Kasanuki H
J Cardiol; 2004 Dec; 44(6):223-32. PubMed ID: 15638220
[TBL] [Abstract][Full Text] [Related]
20. D-dimer levels and stroke progression in patients with acute ischemic stroke and atrial fibrillation.
Krarup LH; Sandset EC; Sandset PM; Berge E
Acta Neurol Scand; 2011 Jul; 124(1):40-4. PubMed ID: 20726843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
